Literature DB >> 7492515

Exposure of macrophages to PLA2-modified lipoproteins leads to cellular lipid accumulations.

M Menschikowski1, P Lattke, S Bergmann, W Jaross.   

Abstract

After a 24-h exposure of mouse peritoneal macrophages to LDL, of which the phospholipids were reduced to 30% by phospholipase A2 (PLA2)-treatment, the cellular level of free and esterified cholesterol was elevated 1.9- and 5.0-fold, respectively. Furthermore, the activity of the cytosolic acyl-CoA cholesterol acyl-transferase (ACAT), which was calculated from the rate of 14C-oleate incorporation into the cellular cholesteryl esters, increased with the degree of LDL hydrolysis. The incubation of macrophages with native HDL led to decreased labeling of cellular cholesteryl esters. However, after PLA2-treatment of HDL the esterification rate increased with the degree of hydrolysis analogous to PLA2-modified LDL. The formation of numerous intracellular lipid droplets was observed by light microscopy after staining with Sudan-III. These data suggest that phospholipases A2 may play a role in the transformation of macrophages into foam-cells, a hallmark of early atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492515

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  3 in total

1.  Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter.

Authors:  Lindsey R Boone; William R Lagor; Margarita de la Llera Moya; Melissa I Niesen; George H Rothblat; Gene C Ness
Journal:  Atherosclerosis       Date:  2011-05-06       Impact factor: 5.162

2.  Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

Authors:  Rolf Eckey; Mario Menschikowski; Peter Lattke; Werner Jaross
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

Review 3.  Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

Authors:  Martina B Lorey; Katariina Öörni; Petri T Kovanen
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.